Möginger, U., Resemann, A., Martin, C. E., Parameswarappa, S., Govindan, S., Wamhoff, E., . . . Kolarich, D. (2016). Cross Reactive Material 197 glycoconjugate vaccines contain privileged conjugation sites. Sci Rep.
Παραπομπή Chicago StyleMöginger, Uwe, et al. "Cross Reactive Material 197 Glycoconjugate Vaccines Contain Privileged Conjugation Sites." Sci Rep 2016.
Παραπομπή MLAMöginger, Uwe, et al. "Cross Reactive Material 197 Glycoconjugate Vaccines Contain Privileged Conjugation Sites." Sci Rep 2016.
Πρόσοχή: Οι παραπομπές μπορεί να μην είναι 100% ακριβείς.